Purpose To determine the prevalence of treatment-related ocular complications and disease
progression following treatment for retinopathy of prematurity (ROP). Methods This was a�…

Purpose To perform a stratified comparison of the short-term risk of retinal detachment after
treatment of type 1 retinopathy of prematurity treated with panretinal photocoagulation laser�…

Purpose To characterize visual outcomes in children screened for retinopathy of prematurity
(ROP). Design Retrospective, interventional case series. Methods Patients who received�…

BACKGROUND: While laser photocoagulation remains the standard of care in the treatment
of advanced retinopathy of prematurity (ROP), regression is not seen in all cases (especially�…

Purpose: To determine the rates and risk factors of recurrent retinopathy of prematurity
(ROP) treated by laser photocoagulation, intravitreal bevacizumab (IVB) monotherapy, or�…

Background Infants with stage 3+ retinopathy of prematurity (ROP) in zone I or zone II
posterior were randomized to initial treatment with bevacizumab or laser in a multicenter trial�…

Purpose: To compare vision and developmental outcomes in infants who were treated with
intravitreal bevacizumab injection (IVB) versus laser for retinopathy of prematurity (ROP)�…

Purpose The treatment of retinopathy of prematurity (ROP) is not standardized and can vary
significantly between providers. This study aims to determine preferred practices in treating�…

Purpose To report 2-year ocular and developmental outcomes for infants receiving low
doses of intravitreal bevacizumab for type 1 retinopathy of prematurity (ROP). Methods A�…

Purpose To evaluate refractive and structural outcomes for patients treated for retinopathy of
prematurity (ROP) with the anti–vascular endothelial growth factor (anti-VEGF) agent�…